We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BOCHGR:ATHEXBank of Cyprus Holdings Plc Analysis

Data as of 2026-09-13 - not real-time

€10.75

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

At €10.75, Bank of Cyprus Holdings Public Limited Company shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have gained 4.9%. RSI sits at 58.6, which reads as neutral, and MACD momentum is bearish. Watch €10.35 as support and €10.84 as the nearer resistance level.
On valuation the read is undervalued — earnings multiple of 9.4 versus a 16.2 sector average, below the peer group. Consensus targets land 9.3% above where the shares trade now. Revenue is growing at 7.1% on a 48.5% profit margin. The 4.57% dividend yield looks covered by current payout levels.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 23.3%, a beta of 0.23 and a maximum drawdown of 16.9%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.

Top Market Events

Seeking Alpha1monBank of Cyprus Holdings Public Limited Company 2026 Q2 - Results - Earnings Call PresentationThe...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 9.33
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 9.4 versus sector average of 16.2
  • Trading above the 200-day average of 9.33

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 9.4 versus sector average of 16.2
  • Analyst targets imply +9.3% versus the current price
  • Profit margin of 48.5% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth7.10%
Profit Margin48.50%
P/E Ratio9.4
ROE17.27%
ROA1.78%
P/B Ratio1.7
Op. Cash Flow€-530862016
Industry P/E16.2

Technical Analysis

TrendBullish
RSI58.6
Support€10.35
Resistance€10.84
MA 20€10.55
MA 50€10.39
MA 200€9.33
MACDBearish
VolumeIncreasing
Fear & Greed Index93.14

Valuation

Target Price€11.75
Upside/Downside9.30%
GradeUndervalued
TypeValue
Dividend Yield4.57%

Risk Assessment

Beta0.23
Volatility23.35%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.